These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9128797)

  • 21. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of anaemia with rHuEpo in patients with MDS.
    Casadevall N
    Med Oncol; 1998 Aug; 15 Suppl 1():S35-7. PubMed ID: 9785335
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaemia in diabetes.
    Thomas S; Rampersad M
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S13-7. PubMed ID: 15103543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alfa-epoietin and anaemia in gynaecological cancer.
    Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
    Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinary erythropoietin excretion: an unknown cause of anemia during nephrotic syndrome].
    Terrier B; Fakhouri F; Sultanik P; Delarue R; Hummel A
    Rev Med Interne; 2006 Aug; 27(8):643-5. PubMed ID: 16876918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1beta and recombinant human erythropoietin therapy.
    Takemasa A; Yorioka N
    Clin Nephrol; 1999 Jul; 52(1):61-2. PubMed ID: 10442499
    [No Abstract]   [Full Text] [Related]  

  • 27. Erythropoietin-dependent anaemia: a possible complication of diabetic neuropathy.
    Hadjadj S; Torremocha F; Fanelli A; Brizard A; Bauwens M; Maréchaud R
    Diabetes Metab; 2001 Jun; 27(3):383-5. PubMed ID: 11431605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature.
    Cervantes F; Alvarez-Larrán A; Hernández-Boluda JC; Sureda A; Torrebadell M; Montserrat E
    Br J Haematol; 2004 Nov; 127(4):399-403. PubMed ID: 15521916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report.
    Lialios G; Makrydimas G; Tsanadis G; Lolis D; Bourantas K
    Minerva Ginecol; 2000; 52(1-2):29-31. PubMed ID: 10851861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current thinking and treatment practices in anaemia--an interactive poll.
    Spivak JL; Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S32-7. PubMed ID: 11188784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indications and limits of recombinant human erythropoietin in intensive care unit].
    Ventré C; Rousseau S; Albanèse J; Leone M; Martin C
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):714-21. PubMed ID: 15324960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant erythropoietin is hope for anemia but is a challenge for doping control].
    Nau JY
    Rev Med Suisse; 2008 Apr; 4(151):871. PubMed ID: 18488755
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant human erythropoietin in the treatment of nonrenal anemia.
    Heuser M; Ganser A
    Ann Hematol; 2006 Feb; 85(2):69-78. PubMed ID: 16078035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A human recombinant erythropoietin produced in human lymphoblastoid cells].
    Bounemra-Ben Ghanem A; Cherif W; Lambin P; Jenhani F; Boukef K
    J Pharm Belg; 1997; 52(5):177-80. PubMed ID: 9432525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M.
    Beirão I; Lobato L; Moreira L; Mp Costa P; Fonseca I; Cabrita A; Porto G
    Amyloid; 2008 Sep; 15(3):205-9. PubMed ID: 18925459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines for the use of rHuEpo in anaemia of malignancy. Department of Internal Medicine and Medical Therapy, University of Pavia Medical school, Pavia, Italy.
    Med Oncol; 1998 Aug; 15 Suppl 1():S50. PubMed ID: 9785338
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of erythropoietin in patients with multiple myeloma.
    Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
    Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromes.
    Ferrero D; Darbesio A; Giai V; Genuardi M; Dellacasa CM; Sorasio R; Bertini M; Boccadoro M
    Br J Haematol; 2009 Feb; 144(3):342-9. PubMed ID: 19036104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.